Literature DB >> 7998959

Binding characteristics of scavenger receptors on liver endothelial and Kupffer cells for modified low-density lipoproteins.

Y B De Rijke1, E A Biessen, C J Vogelezang, T J van Berkel.   

Abstract

Previous studies showed that both endothelial and Kupffer cells contain specific recognition sites of oxidized low-density lipoprotein (OxLDL), in addition to recognition sites which recognize OxLDL and acetylated LDL (AcLDL). We have determined the binding characteristics of the recognition sites for OxLDL on Kupffer cells and endothelial cells (OxLDL-specific binding-site) in comparison to the recognition site for AcLDL on endothelial cells, which recognizes both AcLDL and OxLDL (Ac/OxLDL binding site). The capacity of Kupffer cells to bind OxLDL (Bmax. = 779 ng of 125I-OxLDL/mg of cell protein; Kd = 6 micrograms/ml) was comparable to the binding-capacity of endothelial cells (Bmax. = 803 ng of 125I-OxLDL/mg of cell protein; Kd = 5 micrograms/ml). The effect of net charge of modified LDL on its affinity for the recognition sites on Kupffer and endothelial cells was evaluated using competition studies. The affinity of AcLDL for the Ac/OxLDL binding site was greatly increased from 460 micrograms/ml to 4 micrograms/ml with increasing extent of modification and thus net charge. The Ac/OxLDL binding-site on endothelial cells also displayed an increased affinity towards LDL with an increasing degree of oxidation. The affinity of OxLDL for the Ac/OxLDL binding-site appeared to be about 4-fold higher than that of AcLDL with a similar extent of modification. At higher degrees of oxidation of LDL, the affinity for the OxLDL-specific site on endothelial and Kupffer cells was also strongly enhanced; the OxLDL-specific binding-site possesses a higher affinity for mildly oxidized LDL as compared with the Ac/OxLDL binding-site. It is concluded that recognition of OxLDL by both the OxLDL-specific binding-site and the Ac/OxLDL binding-site on liver endothelial and Kupffer cells depends on the net negative charge of modified LDL. The similarity in binding pattern of these binding sites makes it likely that the newly described 95 kD OxLDL binding protein on Kupffer cells [Y. B. De Rijke and Th. J. C. van Berkel, J. Biol. Chem. (1994), 269, 824-827] contains a recognition site with similar structural elements as described earlier for scavenger receptors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7998959      PMCID: PMC1137453          DOI: 10.1042/bj3040069

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  24 in total

1.  Efficient trace-labelling of proteins with iodine.

Authors:  A S McFARLANE
Journal:  Nature       Date:  1958-07-05       Impact factor: 49.962

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

3.  Separation of plasma lipoproteins by density-gradient ultracentrifugation.

Authors:  T G Redgrave; D C Roberts; C E West
Journal:  Anal Biochem       Date:  1975-05-12       Impact factor: 3.365

4.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts.

Authors:  S K Basu; J L Goldstein; G W Anderson; M S Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

5.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations.

Authors:  D W Bilheimer; S Eisenberg; R I Levy
Journal:  Biochim Biophys Acta       Date:  1972-02-21

6.  Determination of free amino groups in proteins by trinitrobenzenesulfonic acid.

Authors:  A F Habeeb
Journal:  Anal Biochem       Date:  1966-03       Impact factor: 3.365

7.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.

Authors:  S Ylä-Herttuala; M E Rosenfeld; S Parthasarathy; E Sigal; T Särkioja; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

8.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages.

Authors:  A M Fogelman; I Shechter; J Seager; M Hokom; J S Child; P A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

9.  Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells.

Authors:  T J Van Berkel; Y B De Rijke; J K Kruijt
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

10.  Rat liver Kupffer and endothelial cells express different binding proteins for modified low density lipoproteins. Kupffer cells express a 95-kDa membrane protein as a specific binding site for oxidized low density lipoproteins.

Authors:  Y B de Rijke; T J van Berkel
Journal:  J Biol Chem       Date:  1994-01-14       Impact factor: 5.157

View more
  14 in total

1.  Role of liver sinusoidal endothelial cells and stabilins in elimination of oxidized low-density lipoproteins.

Authors:  Ruomei Li; Ana Oteiza; Karen Kristine Sørensen; Peter McCourt; Randi Olsen; Bård Smedsrød; Dmitri Svistounov
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-28       Impact factor: 4.052

2.  Age-related changes in scavenger receptor-mediated endocytosis in rat liver sinusoidal endothelial cells.

Authors:  Jaione Simon-Santamaria; Ivana Malovic; Alessandra Warren; Ana Oteiza; David Le Couteur; Bård Smedsrød; Peter McCourt; Karen Kristine Sørensen
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2010-06-24       Impact factor: 6.053

Review 3.  A Historical Review of Brain Drug Delivery.

Authors:  William M Pardridge
Journal:  Pharmaceutics       Date:  2022-06-16       Impact factor: 6.525

4.  Development of contrast agents targeted to macrophage scavenger receptors for MRI of vascular inflammation.

Authors:  Björn Gustafsson; Susan Youens; Angelique Y Louie
Journal:  Bioconjug Chem       Date:  2006 Mar-Apr       Impact factor: 4.774

5.  Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice.

Authors:  Jeroen J T Otten; Saskia C A de Jager; Annemieke Kavelaars; Tom Seijkens; Ilze Bot; Erwin Wijnands; Linda Beckers; Marijke M Westra; Martine Bot; Matthias Busch; Beatriz Bermudez; Theo J C van Berkel; Cobi J Heijnen; Erik A L Biessen
Journal:  FASEB J       Date:  2012-10-09       Impact factor: 5.191

6.  New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells.

Authors:  M van Oosten; E van de Bilt; T J van Berkel; J Kuiper
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

7.  Plasma oxidized low-density lipoprotein levels and arterial stiffness in older adults: the health, aging, and body composition study.

Authors:  Tina E Brinkley; Barbara J Nicklas; Alka M Kanaya; Suzanne Satterfield; Edward G Lakatta; Eleanor M Simonsick; Kim Sutton-Tyrrell; Stephen B Kritchevsky
Journal:  Hypertension       Date:  2009-03-30       Impact factor: 10.190

Review 8.  Human hepatic sinusoidal endothelial cells can be distinguished by expression of phenotypic markers related to their specialised functions in vivo.

Authors:  P F Lalor; W K Lai; S M Curbishley; S Shetty; D H Adams
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

9.  Development and application of a nonradioactive binding assay of oxidized low-density lipoprotein to macrophage scavenger receptors.

Authors:  Erica N Montano; Agnès Boullier; Felicidad Almazan; Christoph J Binder; Joseph L Witztum; Karsten Hartvigsen
Journal:  J Lipid Res       Date:  2013-08-31       Impact factor: 5.922

10.  Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes.

Authors:  Cecilia Morgantini; Satoshi Imaizumi; Victor Grijalva; Mohamad Navab; Alan M Fogelman; Srinivasa T Reddy
Journal:  Diabetes       Date:  2010-09-08       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.